
Sign up to save your podcasts
Or


New weight loss medications and the doors they have opened up. A look at what's possible with the addition of newer therapeutics to older therapeutics. Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP1 receptor agonists and how they are changing the face of obesity medicine.
https://dralo.net/links
By Cardiologist & Personal Trainer Dr. Alo4.9
141141 ratings
New weight loss medications and the doors they have opened up. A look at what's possible with the addition of newer therapeutics to older therapeutics. Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP1 receptor agonists and how they are changing the face of obesity medicine.
https://dralo.net/links

7,362 Listeners

1,546 Listeners

491 Listeners

2,626 Listeners

4,912 Listeners

3,531 Listeners

9,258 Listeners

9,079 Listeners

330 Listeners

1,113 Listeners

50 Listeners

29,194 Listeners

232 Listeners

393 Listeners

1,182 Listeners